Astrotech Corporation (ASTC) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Astrotech Corporation (ASTC) Industrial Operations Profile

Astrotech Corporation, operating within the Industrials sector, focuses on science and technology development, particularly mass spectrometry. Its segments cater to explosives detection, cannabis analysis, and breath analysis, positioning it as a diversified technology commercialization company with a small market capitalization.

What Is the Investment Thesis for ASTC?

Astrotech Corporation presents a speculative investment thesis centered on its technology commercialization efforts, particularly in the explosives detection and cannabis analysis markets. The company's negative P/E ratio of -0.29 and a significant negative profit margin of -1163.9% indicate substantial financial challenges. However, potential growth catalysts include the broader adoption of TRACER 1000 in security applications and the expansion of AgLAB-1000 in the burgeoning cannabis industry. Investors should closely monitor the company's ability to improve its financial performance and successfully commercialize its technologies. The company's small market capitalization and high beta of 0.37 suggest significant volatility and risk.

Based on FMP financials and quantitative analysis

ASTC Key Highlights

• Market capitalization of $12.8M indicates a micro-cap company with high growth potential but also significant risk.
• P/E ratio of -0.29 reflects current losses, suggesting the company's earnings are negative.
• Profit margin of -1163.9% highlights substantial operational inefficiencies and challenges in achieving profitability.
• Gross margin of 14.7% indicates a limited ability to control production costs.
• Beta of 0.37 suggests lower volatility compared to the overall market.

Who Are ASTC's Competitors?

ASTC is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are ASTC's Key Strengths?

• Proprietary AMS Technology platform
• Specialized expertise in mass spectrometry
• Established presence in niche markets
• Diverse product portfolio across multiple segments

What Are ASTC's Weaknesses?

• Negative profitability and high operating losses
• Small market capitalization and limited financial resources
• Dependence on successful commercialization of new products
• Limited brand recognition compared to larger competitors

What Could Drive ASTC Stock Higher?

• Potential regulatory approvals for TRACER 1000 in international markets.
• Expansion of AgLAB-1000 sales in the cannabis industry.
• Development and commercialization of BreathTest-1000 for medical applications.

What Are the Key Risks for ASTC?

• Financial-distress signal — its Altman Z-Score of -22.82 sits in the distress zone (elevated bankruptcy risk).
• Negative return on equity (-81.8%) — the business is not currently generating profit on shareholder capital.
• Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
• Intense competition from larger companies in the security and analytical instrumentation markets.
• Regulatory hurdles and compliance requirements for explosives detection and cannabis testing.
• Negative profitability and high operating losses.
• Dependence on successful commercialization of new products.

What Are the Growth Opportunities for ASTC?

• Expansion of TRACER 1000 in Security Applications: The increasing need for enhanced security measures at airports, secured facilities, and borders presents a significant growth opportunity for Astrotech's 1st Detect segment. Successful deployment and adoption of TRACER 1000 as a replacement for existing explosives trace detectors could drive substantial revenue growth. The timeline for realizing this opportunity depends on regulatory approvals and market acceptance.
• Penetration of AgLAB-1000 in the Cannabis Market: The burgeoning cannabis industry requires accurate and reliable testing solutions for quality control and regulatory compliance. Astrotech's AgLAB-1000 mass spectrometer offers a potential solution for analyzing hemp and cannabis products. The cannabis testing market is expected to grow significantly in the coming years, providing a favorable environment for AgLAB's expansion. Success hinges on product validation and market penetration strategies.
• Commercialization of BreathTest-1000 for Medical Applications: Astrotech's BreathTest-1000, designed to screen for volatile organic compound metabolites in a person's breath, has potential applications in medical diagnostics and health monitoring. The breath analysis market is expanding, driven by advancements in sensor technology and increasing demand for non-invasive diagnostic tools. Successful development and commercialization of BreathTest-1000 could open new revenue streams for Astrotech.
• Licensing of AMS Technology: Astrotech Technologies, Inc. (ATI) owns and licenses the AMS Technology, a platform mass spectrometry technology. Expanding the licensing of this technology to other companies and research institutions could generate recurring revenue streams for Astrotech. The market for mass spectrometry technologies is broad, encompassing various applications in pharmaceuticals, environmental monitoring, and materials science. The timeline for realizing this opportunity depends on successful technology transfer and market demand.
• Strategic Partnerships and Acquisitions: Astrotech could pursue strategic partnerships or acquisitions to expand its technology portfolio, market reach, and customer base. Collaborating with complementary technology providers or acquiring companies with established market positions could accelerate Astrotech's growth trajectory. The timeline for realizing this opportunity depends on identifying suitable partners or acquisition targets and successfully integrating them into Astrotech's operations.

What Opportunities Does ASTC Have?

• Expansion in the growing cannabis testing market
• Increased demand for advanced security technologies
• Potential applications of breath analysis tools in medical diagnostics
• Strategic partnerships and acquisitions to expand market reach

What Threats Does ASTC Face?

• Intense competition from larger, more established players
• Regulatory hurdles and compliance requirements
• Technological obsolescence and rapid advancements in the industry
• Economic downturns and reduced government spending on security

What Are ASTC's Competitive Advantages?

• Proprietary AMS Technology platform.
• Specialized expertise in mass spectrometry applications.
• Established presence in niche markets such as explosives detection.

What Does ASTC Do?

Astrotech Corporation, originally founded in 1984 as SPACEHAB, Inc. and rebranded in 2009, is a science and technology development and commercialization company. Headquartered in Austin, Texas, the company operates through three primary segments: Astrotech Technologies, Inc. (ATI), 1st Detect Corporation, and AgLAB Inc. ATI focuses on owning and licensing the AMS Technology, a platform mass spectrometry technology. 1st Detect manufactures explosives and narcotics trace detectors, notably the TRACER 1000, aimed at replacing existing detection systems in airports, secured facilities, and borders. AgLAB develops mass spectrometry tools, including AgLAB-1000 for the hemp and cannabis market, and BreathTest-1000, a breath analysis tool designed to screen for volatile organic compound metabolites. Astrotech's business model centers on developing and commercializing innovative technologies across diverse sectors, leveraging its expertise in mass spectrometry to address specific market needs. Despite its innovative focus, the company faces challenges related to profitability and market penetration.

What Products and Services Does ASTC Offer?

• Develops and commercializes science and technology solutions.
• Operates through three segments: Astrotech Technologies, 1st Detect, and AgLAB.
• Licenses AMS Technology, a platform mass spectrometry technology.
• Manufactures explosives and narcotics trace detectors.
• Provides TRACER 1000 for explosives detection at airports and secured facilities.
• Develops AgLAB-1000 for use in the hemp and cannabis market.
• Develops BreathTest-1000 for breath analysis.

How Does ASTC Make Money?

• Develops and commercializes technology products.
• Generates revenue through product sales and licensing agreements.
• Targets specific markets such as security, cannabis, and medical diagnostics.

What Industry Does ASTC Operate In?

Astrotech Corporation operates in the Aerospace & Defense industry, specifically within the technology development and commercialization niche. The industry is characterized by intense competition, rapid technological advancements, and stringent regulatory requirements. Astrotech's focus on mass spectrometry applications for explosives detection and cannabis analysis positions it in specialized segments of the broader market. The company competes with larger, more established players in the security and analytical instrumentation sectors. Market trends include increasing demand for advanced security technologies and growing interest in cannabis testing solutions.

Who Are ASTC's Key Customers?

• Airports and secured facilities requiring explosives detection.
• Hemp and cannabis testing laboratories.
• Potential customers for breath analysis tools in medical and health monitoring.

F-Score 2/9Financial Health

Astrotech Corporation's Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -22.82 places it in the distress zone, a signal of elevated financial risk.

Quarterly Financial Performance: Astrotech Corporation

Revenue for Astrotech Corporation came in at $343K during Q1 2026, a 131.8% improvement versus the preceding quarter. The company recorded a net loss of $3.8M, with diluted EPS of $-2.25. Quarter-over-quarter revenue has been mixed, typical for a micro-cap company operating in Industrials. Across the four most recent quarters, ASTC averaged $-2.10 in diluted EPS.

ASTC Valuation & Market Position

With a $12.8M market cap, Astrotech Corporation sits in the micro-cap segment of the market. Relative to its peer group, ASTC's quantitative score of 17/100 is below the peer average of 56/100.

ROE -82%Key Financial Metrics

Return on equity for Astrotech Corporation stands at -81.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -87.1%, showing how much profit it generates from its asset base. Its free cash flow yield is -32.7%, a gauge of the cash the business throws off relative to its market value. A current ratio of 6.17 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -32.9%, the inverse of the P/E and a quick read on earnings relative to price.

Company Profile

Astrotech Corporation operates in the Aerospace & Defense industry within the Industrials sector. It is headquartered in Austin, US. The company is led by CEO Thomas Boone Pickens. ASTC has traded publicly since 1995.

ASTC Financials

ASTC Latest News

ASTC Analyst Consensus

ASTC MoonshotScore

What Investors Ask About Astrotech Corporation (ASTC) — Industrials

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources